Inflammation-Modulating Effect of Butyrate in the Prevention of Colon Cancer by Dietary Fiber

Clinical Colorectal Cancer

Volumn 17, Issue 3, 2018, Pages e541-e544

  Chen, Jiezhong ^a   Vitetta, Luis ^a,b  

^a Medlab   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Butyrate; Dietary fiber; Proinflammatory cytokines; Signaling pathways; T regulatory cells

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE; BUTYRIC ACID DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; CELL SURVIVAL; COLON CANCER; CYTOKINE PRODUCTION; DIETARY FIBER; ENZYME INHIBITION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NOTE; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; ADMINISTRATION AND DOSAGE; COLON TUMOR; IMMUNOLOGY; INTESTINE; INTESTINE FLORA; METABOLISM; MICROBIOLOGY;

APOPTOSIS; BUTYRATES; CELL PROLIFERATION; COLONIC NEOPLASMS; DIETARY FIBER; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; INTESTINES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 85047820988     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2018.05.001     Document Type: Note

References (25)

1. Sender, R., Fuchs, S., Milo, R., Revised estimates for the number of human and bacteria cells in the body. PLoS Biol, 14, 2016, e1002533.
2. Park, S.Y., Wilkens, L.R., Kolonel, L.N., Henderson, B.E., Le Marchand, L., Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study. Int J Cancer 139 (2016), 1241–1250.
3. Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., Brummer, R.J., Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27 (2008), 104–119.
4. Gantois, I., Ducatelle, R., Pasmans, F., et al. Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol 72 (2006), 946–949.
5. O'Keefe, S.J., Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol 13 (2016), 691–706.
6. Shaw, E., Warkentin, M.T., McGregor, S.E., Town, S., Hilsden, R.J., Brenner, D.R., Intake of dietary fibre and lifetime non-steroidal anti-inflammatory drug (NSAID) use and the incidence of colorectal polyps in a population screened for colorectal cancer. J Epidemiol Community Health 71 (2017), 961–969.
7. Kopp, T.I., Vogel, U., Tjonneland, A., Andersen, V., Meat and fiber intake and interaction with pattern recognition receptors (TLR1, TLR2, TLR4, and TLR10) in relation to colorectal cancer in a Danish prospective, case–cohort study. Am J Clin Nutr 107 (2018), 465–479.
8. Zhang, M., Zhou, Q., Dorfman, R.G., et al. Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol, 16, 2016, 84.
9. Zeng, H., Taussig, D.P., Cheng, W.H., Johnson, L.K., Hakkak, R., Butyrate inhibits cancerous HCT116 colon cell proliferation but to a lesser extent in noncancerous NCM460 colon cells. Nutrients, 9, 2017, 25.
10. Bishehsari, F., Engen, P.A., Preite, N.Z., et al. Dietary fiber treatment corrects the composition of gut microbiota, promotes SCFA production, and suppresses colon carcinogenesis. Genes, 9, 2018, 10.3390/genes9020102.
11. Greten, F.R., Eckmann, L., Greten, T.F., et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004), 285–296.
12. Park, E.J., Lee, J.H., Yu, G.Y., et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140 (2010), 197–208.
13. Potten, C.S., Kellett, M., Roberts, S.A., Rew, D.A., Wilson, G.D., Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut 33 (1992), 71–78.
14. Zhao, R., Michor, F., Patterns of proliferative activity in the colonic crypt determine crypt stability and rates of somatic evolution. PLoS Comput Biol, 9, 2013, e1003082.
15. Johnson, D.E., O'Keefe, R.A., Grandis, J.R., Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 15 (2018), 234–248.
16. Ibrahim, S., Girault, A., Ohresser, M., et al. Monoclonal antibodies targeting the IL-17/IL-17RA axis: an opportunity to improve the efficiency of anti-VEGF therapy in fighting metastatic colorectal cancer?. Clin Colorectal Cancer 17 (2018), e109–e113.
17. Lee, H.H., Yang, S.S., Vo, M.T., et al. Tristetraprolin down-regulates IL-23 expression in colon cancer cells. Molecules Cells 36 (2013), 571–576.
18. Pikarsky, E., Porat, R.M., Stein, I., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004), 461–466.
19. Font-Burgada, J., Sun, B., Karin, M., Obesity and cancer: the oil that feeds the flame. Cell Metab 23 (2016), 48–62.
20. Kitamura, H., Ohno, Y., Toyoshima, Y., et al. Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy. Cancer Sci 108 (2017), 1947–1952.
21. Maeda, S., Omata, M., Inflammation and cancer: role of nuclear factor–kappaB activation. Cancer Sci 99 (2008), 836–842.
22. Yen, D., Cheung, J., Scheerens, H., et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116 (2006), 1310–1316.
23. Punkenburg, E., Vogler, T., Buttner, M., et al. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer. Gut 65 (2016), 1139–1150.
24. Singh, N., Gurav, A., Sivaprakasam, S., et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40 (2014), 128–139.
25. + regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326 (2009), 986–991.